The control group (Group 2) included 87 patients (87 eyes) who did not develop VH after intravitreal anti-VEGF injection after diagnosis of AMD with SMH during the 6-month follow-up; these patients were age-and sex-matched to Group 1 patients. The gene discussed is VEGFA; the disease is age-related macular degeneration.